273 related articles for article (PubMed ID: 29385753)
21. A mouse model of paralytic myelitis caused by enterovirus D68.
Hixon AM; Yu G; Leser JS; Yagi S; Clarke P; Chiu CY; Tyler KL
PLoS Pathog; 2017 Feb; 13(2):e1006199. PubMed ID: 28231269
[TBL] [Abstract][Full Text] [Related]
22. Immunogenicity and protective efficacy of an EV71 virus-like particle vaccine against lethal challenge in newborn mice.
Sun S; Gao F; Mao Q; Shao J; Jiang L; Liu D; Wang Y; Yao X; Wu X; Sun B; Zhao D; Ma Y; Lu J; Kong W; Jiang C; Liang Z
Hum Vaccin Immunother; 2015; 11(10):2406-13. PubMed ID: 26036916
[TBL] [Abstract][Full Text] [Related]
23. Formalin-inactivated vaccine provokes cross-protective immunity in a mouse model of human enterovirus 71 infection.
Bek EJ; Hussain KM; Phuektes P; Kok CC; Gao Q; Cai F; Gao Z; McMinn PC
Vaccine; 2011 Jun; 29(29-30):4829-38. PubMed ID: 21550375
[TBL] [Abstract][Full Text] [Related]
24. An inactivated whole-virion vaccine for Enterovirus D68 adjuvanted with CpG ODN or AddaVax elicits potent protective immunity in mice.
Senpuku K; Kataoka-Nakamura C; Kunishima Y; Hirai T; Yoshioka Y
Vaccine; 2024 Apr; 42(9):2463-2474. PubMed ID: 38472067
[TBL] [Abstract][Full Text] [Related]
25. Intranasal immunization with coxsackievirus A16 virus-like particles confers protection against lethal infection in neonatal mice.
Chen X; Zhang Y; Mao N; Zhu S; Ji T; Xu W
Arch Virol; 2019 Dec; 164(12):2975-2984. PubMed ID: 31570994
[TBL] [Abstract][Full Text] [Related]
26. Current Understanding of Humoral Immunity to Enterovirus D68.
Vogt MR; Crowe JE
J Pediatric Infect Dis Soc; 2018 Dec; 7(suppl_2):S49-S53. PubMed ID: 30590621
[TBL] [Abstract][Full Text] [Related]
27. Neutralizing Antibody Given after Paralysis Onset Reduces the Severity of Paralysis Compared to Nonspecific Antibody-Treated Controls in a Mouse Model of EV-D68-Associated Acute Flaccid Myelitis.
Rudy MJ; Frost J; Clarke P; Tyler KL
Antimicrob Agents Chemother; 2022 Aug; 66(8):e0022722. PubMed ID: 35894595
[TBL] [Abstract][Full Text] [Related]
28. Contemporary Circulating Enterovirus D68 Strains Have Acquired the Capacity for Viral Entry and Replication in Human Neuronal Cells.
Brown DM; Hixon AM; Oldfield LM; Zhang Y; Novotny M; Wang W; Das SR; Shabman RS; Tyler KL; Scheuermann RH
mBio; 2018 Oct; 9(5):. PubMed ID: 30327438
[TBL] [Abstract][Full Text] [Related]
29. Neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice.
Yu CK; Chen CC; Chen CL; Wang JR; Liu CC; Yan JJ; Su IJ
J Biomed Sci; 2000; 7(6):523-8. PubMed ID: 11060501
[TBL] [Abstract][Full Text] [Related]
30. Telaprevir Treatment Reduces Paralysis in a Mouse Model of Enterovirus D68 Acute Flaccid Myelitis.
Frost J; Rudy MJ; Leser JS; Tan H; Hu Y; Wang J; Clarke P; Tyler KL
J Virol; 2023 May; 97(5):e0015623. PubMed ID: 37154751
[TBL] [Abstract][Full Text] [Related]
31. Identification and characterization of a cross-neutralization epitope of Enterovirus 71.
Liu CC; Chou AH; Lien SP; Lin HY; Liu SJ; Chang JY; Guo MS; Chow YH; Yang WS; Chang KH; Sia C; Chong P
Vaccine; 2011 Jun; 29(26):4362-72. PubMed ID: 21501643
[TBL] [Abstract][Full Text] [Related]
32. A comparative study of multiple clinical enterovirus 71 isolates and evaluation of cross protection of inactivated vaccine strain FY-23 K-B in vitro.
Yang T; Li H; Yue L; Song X; Xie T; Ma S; Meng H; Zhang Y; He X; Long R; Yang R; Luo F; Xie Z; Li Q
Virol J; 2017 Oct; 14(1):206. PubMed ID: 29073897
[TBL] [Abstract][Full Text] [Related]
33. Human Enterovirus 71 Protein Displayed on the Surface of Saccharomyces cerevisiae as an Oral Vaccine.
Zhang C; Wang Y; Ma S; Li L; Chen L; Yan H; Peng T
Viral Immunol; 2016 Jun; 29(5):288-95. PubMed ID: 27259043
[TBL] [Abstract][Full Text] [Related]
34. A neonatal mouse model for the evaluation of antibodies and vaccines against coxsackievirus A6.
Yang L; Mao Q; Li S; Gao F; Zhao H; Liu Y; Wan J; Ye X; Xia N; Cheng T; Liang Z
Antiviral Res; 2016 Oct; 134():50-57. PubMed ID: 27582066
[TBL] [Abstract][Full Text] [Related]
35. A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice.
Yang L; Liu Y; Li S; Zhao H; Lin Q; Yu H; Huang X; Zheng Q; Cheng T; Xia N
Vaccine; 2016 Nov; 34(48):5938-5945. PubMed ID: 27771182
[TBL] [Abstract][Full Text] [Related]
36. An adult gerbil model for evaluating potential coxsackievirus A16 vaccine candidates.
Yao PP; Miao ZP; Xu F; Lu HJ; Sun YS; Xia Y; Chen C; Yang ZN; Xia SC; Jiang JM; Hu CG; Mao ZA; Gao M; Xu ZY; Ying HN; Yao CH; Zhu ZY; Zhu HP; Xiang HQ
Vaccine; 2019 Aug; 37(36):5341-5349. PubMed ID: 31351798
[TBL] [Abstract][Full Text] [Related]
37. Muscle destruction caused by coxsackievirus A10 in gerbils: Construction of a novel animal model for antiviral evaluation.
Chen C; Xia Y; Zhu S; Xu F; Sun Y; Lu H; Gao M; Yang Z; Mao Z; Ge Q; Miao Z; Zhu H; Yao P
Virus Res; 2020 Sep; 286():198067. PubMed ID: 32553610
[TBL] [Abstract][Full Text] [Related]
38. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge.
Chung YC; Ho MS; Wu JC; Chen WJ; Huang JH; Chou ST; Hu YC
Vaccine; 2008 Mar; 26(15):1855-62. PubMed ID: 18329759
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
[TBL] [Abstract][Full Text] [Related]
40. Clinically isolated enterovirus A71 subgenogroup C4 strain with lethal pathogenicity in 14-day-old mice and the application as an EV-A71 mouse infection model.
Xu Y; Ma S; Zhu L; Huang Z; Chen L; Xu Y; Yin H; Peng T; Wang Y
Antiviral Res; 2017 Jan; 137():67-75. PubMed ID: 27864074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
